PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $790 | +54.6% | 45,587 | +137.4% | 0.07% | +33.3% |
| Q1 2023 | $511 | +30.4% | 19,206 | -5.2% | 0.05% | +4.1% |
| Q4 2022 | $392 | -99.9% | 20,259 | -8.9% | 0.05% | -21.0% |
| Q3 2022 | $464,000 | -20.7% | 22,235 | -69.6% | 0.06% | -29.5% |
| Q2 2022 | $585,000 | +22.4% | 73,053 | +7.1% | 0.09% | +37.5% |
| Q1 2022 | $478,000 | -39.6% | 68,236 | +16.5% | 0.06% | -35.4% |
| Q4 2021 | $791,000 | +81.0% | 58,593 | +126.5% | 0.10% | +120.0% |
| Q3 2021 | $437,000 | – | 25,867 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
| CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
| TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
| Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
| Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
| Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
| HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
| Grace Capital | 48,058 | $808,000 | 0.50% |
| Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
| Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |